Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Electromed (ELMD) stocks in Canada

Learn how to easily invest in Electromed stocks.

Electromed is a medical devices business based in the US. Electromed stocks (ELMD.US) are listed on the NYSE MKT and all prices are listed in US Dollars. Its last market close was $11.35 – an increase of 0.47% over the previous week. Electromed employs 132 staff and has a trailing 12-month revenue of around $37.8 million.

How to buy shares in Electromed

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ELMD – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Electromed stock price (NYSE MKT:ELMD)

Use our graph to track the performance of ELMD stocks over time.

Electromed shares at a glance

Information last updated 2022-01-17.
Latest market close$12.77
52-week range$8.98 - $13.85
50-day moving average $12.32
200-day moving average $11.40
Wall St. target price$21.00
PE ratio 48.8846
Dividend yield N/A (0%)
Earnings per share (TTM) $0.26

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Electromed stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Electromed price performance over time

Historical closes compared with the close of $12.77 from 2022-01-21

1 week (2022-01-13) 0.16%
1 month (2021-12-20) N/A
3 months (2021-10-22) 17.05%
6 months (2021-07-23) 6.42%
1 year (2021-01-22) 27.06%
2 years (2020-01-24) 34.27%
3 years (2019-01-24) 139.59%
5 years (2017-01-24) 226.60%

Is Electromed under- or over-valued?

Valuing Electromed stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Electromed's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Electromed's P/E ratio

Electromed's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 49x. In other words, Electromed shares trade at around 49x recent earnings.

Electromed's EBITDA

Electromed's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.6 million.

The EBITDA is a measure of a Electromed's overall financial performance and is widely used to measure a its profitability.

Electromed financials

Revenue TTM $37.8 million
Operating margin TTM 7.99%
Gross profit TTM $27.3 million
Return on assets TTM 5.21%
Return on equity TTM 7.09%
Profit margin 6%
Book value $3.86
Market capitalisation $108.9 million

TTM: trailing 12 months

Electromed share dividends

We're not expecting Electromed to pay a dividend over the next 12 months.

Electromed share price volatility

Over the last 12 months, Electromed's shares have ranged in value from as little as $8.98 up to $13.85. A popular way to gauge a stock's volatility is its "beta".

ELMD.US volatility(beta: 0.65)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Electromed's is 0.6533. This would suggest that Electromed's shares are less volatile than average (for this exchange).

Electromed overview

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site